U.S. Clinical Trial Evaluating Antiviral for Monkeypox Begins
September 9, 2022 -- A Phase 3 clinical trial evaluating the antiviral tecovirimat, also known as TPOXX, is now enrolling adults and children with monkeypox infection in the United States. Study investigators aim to enroll more than 500 people from... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 9, 2022 Category: Pharmaceuticals Source Type: clinical trials
Tecovirimat in Non-hospitalized Patients With Monkeypox
Condition: Monkeypox Interventions: Drug: Tecovirimat; Drug: Placebo Sponsors: Marina Klein; McGill University Health Centre/Research Institute of the McGill University Health Centre; University Health Network, Toronto; Unity Health Toronto; University of British Columbia; CIHR Canadian HIV Trials Network Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 9, 2022 Category: Research Source Type: clinical trials
